Martingale Asset Management L P Eli Lilly & CO Transaction History

Martingale Asset Management L P

$4.56 Billion
Q2 2024

A detailed history of Martingale Asset Management L P transactions in Eli Lilly & CO stock. As of the latest transaction made, Martingale Asset Management L P holds 69,332 shares of LLY stock, worth $63 Million. This represents 1.38% of its overall portfolio holdings.

Number of Shares

69,332

Previous 83,661 17.13%

Holding current value

$63 Million

Previous $65.1 Million 3.55%

% of portfolio

1.38%

Previous 1.31%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$724.87 - $909.04 $10.4 Million - $13 Million	-14,329 Reduced 17.13%	69,332 $62.8 Million
Q1 2024 May 14, 2024	SELL	$592.2 - $792.28 $3.49 Million - $4.67 Million	-5,898 Reduced 6.59%	83,661 $65.1 Million
Q4 2023 Feb 12, 2024	SELL	$525.19 - $619.13 $11.8 Million - $14 Million	-22,549 Reduced 20.11%	89,559 $52.2 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $14.3 Million - $19.8 Million	-33,004 Reduced 22.74%	112,108 $60.2 Million
Q2 2023 Aug 11, 2023	SELL	$350.74 - $468.98 $12.6 Million - $16.9 Million	-35,981 Reduced 19.87%	145,112 $68.1 Million
Q1 2023 May 12, 2023	SELL	$310.63 - $364.82 $1.17 Million - $1.37 Million	-3,761 Reduced 2.03%	181,093 $62.2 Million
Q4 2022 Feb 13, 2023	SELL	$321.55 - $374.67 $7.02 Million - $8.18 Million	-21,839 Reduced 10.57%	184,854 $67.6 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $4.36 Million - $4.97 Million	-14,717 Reduced 6.65%	206,693 $66.8 Million
Q2 2022 Aug 11, 2022	SELL	$278.73 - $327.27 $12.9 Million - $15.2 Million	-46,374 Reduced 17.32%	221,410 $71.8 Million
Q1 2022 May 12, 2022	SELL	$234.69 - $291.66 $6.84 Million - $8.5 Million	-29,155 Reduced 9.82%	267,784 $76.7 Million
Q4 2021 Feb 11, 2022	SELL	$224.85 - $279.04 $6.84 Million - $8.49 Million	-30,416 Reduced 9.29%	296,939 $82 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $20.5 Million - $25.2 Million	-92,476 Reduced 22.03%	327,355 $75.6 Million
Q2 2021 Aug 13, 2021	SELL	$180.55 - $233.54 $8.77 Million - $11.3 Million	-48,581 Reduced 10.37%	419,831 $96.4 Million
Q1 2021 May 13, 2021	SELL	$164.32 - $212.72 $9.15 Million - $11.8 Million	-55,655 Reduced 10.62%	468,412 $87.5 Million
Q4 2020 Feb 10, 2021	BUY	$130.46 - $172.63 $639,384 - $846,059	4,901 Added 0.94%	524,067 $88.5 Million
Q3 2020 Nov 12, 2020	SELL	$146.22 - $169.13 $658,136 - $761,254	-4,501 Reduced 0.86%	519,166 $76.8 Million
Q2 2020 Aug 10, 2020	SELL	$136.42 - $164.18 $1.48 Million - $1.79 Million	-10,885 Reduced 2.04%	523,667 $86 Million
Q1 2020 May 11, 2020	BUY	$119.05 - $147.35 $1.83 Million - $2.27 Million	15,388 Added 2.96%	534,552 $74.2 Million
Q4 2019 Feb 10, 2020	BUY	$106.92 - $132.43 $3.01 Million - $3.72 Million	28,110 Added 5.72%	519,164 $68.2 Million
Q3 2019 Nov 13, 2019	BUY	$106.79 - $116.16 $3.5 Million - $3.81 Million	32,800 Added 7.16%	491,054 $54.9 Million
Q2 2019 Aug 13, 2019	SELL	$110.79 - $129.32 $699,749 - $816,785	-6,316 Reduced 1.36%	458,254 $0
Q1 2019 May 08, 2019	SELL	$111.31 - $131.02 $10.3 Million - $12.1 Million	-92,603 Reduced 16.62%	464,570 $0
Q4 2018 Feb 11, 2019	SELL	$105.9 - $118.64 $7.42 Million - $8.31 Million	-70,061 Reduced 11.17%	557,173 $64.5 Million
Q3 2018 Nov 09, 2018	SELL	$85.86 - $107.31 $983,440 - $1.23 Million	-11,454 Reduced 1.79%	627,234 $0
Q2 2018 Aug 09, 2018	BUY	$75.7 - $86.88 $673,502 - $772,971	8,897 Added 1.41%	638,688 $0
Q1 2018 May 11, 2018	BUY	$74.21 - $87.6 $5.2 Million - $6.14 Million	70,107 Added 12.53%	629,791 $0
Q4 2017 Feb 12, 2018	BUY	$81.94 - $87.89 $1.61 Million - $1.72 Million	19,614 Added 3.63%	559,684 $0
Q3 2017 Nov 13, 2017	BUY	$77.07 - $85.54 $41.6 Million - $46.2 Million	540,070	540,070 $46.2 Million

Others Institutions Holding LLY

# of Institutions

3,887

Shares Held

763M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $864B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Martingale Asset Management L P with notifications on news.

Account

Martingale Asset Management L P Eli Lilly & CO Transaction History